ModifiedAmbetter NevadaPolicy CP.MP.82

Clinical Policy: NICU Apnea Bradycardia Guidelines

Customize your policy alerts

Sign up for Ambetter Nevada Policy CP.MP.82 alerts

Get alerted when Policy CP.MP.82 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Guides inpatient discharge planning, continuity of care, transition to outpatient or home care, and approval of continued neonatal inpatient stays for infants with apnea, bradycardia, desaturation events, or recent caffeine administration.

Policy Summary

PayerAmbetter Nevada

PolicyNICU Apnea Bradycardia Guidelines

Policy CodePolicy CP.MP.82

Change TypeModified

Effective DateOct 1, 2026

Last ReviewJun 1, 2026

Next Review DateN/A

Key ActionDocument cardiorespiratory event frequency, duration, heart rate, oxygen saturation, feeding status, interventions, and recovery requirements during the observation period.

SourceLink

POLICY UPDATE CHANGES

The policy clarified the criteria for clinically significant bradycardia, reflux-associated events, and the response required from anti-reflux measures.

The policy removed the prior criterion requiring discharge home with a cardiorespiratory monitor and removed wording about providing stimulation in the non-clinically significant apnea criterion.

The clinically significant event definition includes oxygen desaturation of 85% or less in specified circumstances and isolated bradycardia below 80 beats per minute.

5-7 daysEvent-free observation

<80 bpmBradycardia threshold

≤85%

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

ModifiedAmbetter NevadaPolicy CP.MP.82

Clinical Policy: NICU Apnea Bradycardia Guidelines

Customize your policy alerts

Sign up for Ambetter Nevada Policy CP.MP.82 alerts

Get alerted when Policy CP.MP.82 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerAmbetter Nevada

PolicyNICU Apnea Bradycardia Guidelines

Policy CodePolicy CP.MP.82

Change TypeModified

Effective DateOct 1, 2026

Last ReviewJun 1, 2026

Next Review DateN/A

Key ActionDocument cardiorespiratory event frequency, duration, heart rate, oxygen saturation, feeding status, interventions, and recovery requirements during the observation period.

SourceLink

POLICY UPDATE CHANGES

The policy clarified the criteria for clinically significant bradycardia, reflux-associated events, and the response required from anti-reflux measures.

The policy removed the prior criterion requiring discharge home with a cardiorespiratory monitor and removed wording about providing stimulation in the non-clinically significant apnea criterion.

The clinically significant event definition includes oxygen desaturation of 85% or less in specified circumstances and isolated bradycardia below 80 beats per minute.

5-7 daysEvent-free observation

<80 bpmBradycardia threshold

≤85%

Desaturation threshold

≥20 secApnea duration

7 daysCaffeine-free interval

<37 weeksGestational-age threshold

Discharge Readiness Criteria

Discharge from inpatient care for significant cardiorespiratory events

Infants may be considered ready for discharge from inpatient care for significant cardiorespiratory events or caffeine administration when all applicable requirements are met.

Overall discharge readiness

Respiratory-control maturity pathway
- No clinically significant events
  - Event criteria: There is no apnea lasting 20 seconds or longer; no apnea shorter than 20 seconds with clinically significant bradycardia; no apnea shorter than 20 seconds with valid, prolonged, or frequent desaturations; no isolated bradycardia unrelated to feedings; and no event requiring stimulation, artificial ventilation, or supplemental oxygen to restore normal breathing, heart rate, and oxygenation.Apnea ≥ 20 seconds; bradycardia < 80 beats per minute; desaturation ≤ 85%
    Transient oxygen desaturation at or below 85% is excluded unless supplemental oxygen is required to resolve it.
- Reflux-associated persistent events: For clinically significant events persisting in an infant approaching term gestation or beyond, evaluation for potential causes has been completed; events appear temporally associated with gastroesophageal reflux; there is no evidence of another acute condition requiring inpatient management; and appropriate anti-reflux measures resolve or significantly reduce the severity and duration of bradycardia or apnea events.
  Five days of observation may not be required in this circumstance.
- Non-clinically significant self-limited apnea: The infant has self-limited apnea spells without color change or severe bradycardia, does not require stimulation to resume breathing, has had no clinically significant cardiorespiratory event for five to seven days, the parent(s) or caregiver(s) agree with the plan of care and have completed infant CPR training, and the home situation has been assessed and deemed adequate.5–7 days without a clinically significant event
Nasal-cannula support: If nasal-cannula airflow was introduced to address apnea or bradycardia events, the infant is free of clinically significant events for five to seven days on the same level of support planned for discharge.5–7 days on planned support
Applies when nasal-cannula airflow is introduced to address apnea or bradycardia events.
Caffeine-free interval: The infant has not received caffeine citrate for at least seven days before planned discharge.≥ 7 days
No other inpatient condition: The infant has no additional condition requiring inpatient care.

Transient oxygen desaturation at or below 85% is not considered a clinically significant desaturation for discharge-readiness purposes unless supplemental oxygen is required to resolve it. Clinically significant desaturation includes valid, prolonged, or frequent episodes at or below 85%. Events requiring stimulation, bagging, intubation, or supplemental oxygen to restore normal breathing, heart rate, or oxygenation do not meet the non-event pathway.

Cardiorespiratory episodes occurring during oral feeding require individualized clinical evaluation. Assess the severity of bradycardia, degree of oxygen desaturation, interventions required, and the infant's feeding coordination, recognizing that feeding-associated episodes may not have the same clinical significance as episodes recorded during sleep. Caregivers should be instructed how to identify feeding problems and correct them.

Clinical Event Thresholds

Apnea duration

Clinically significant apnea thresholdAt least 20 seconds

Shorter apnea with bradycardiaAn apnea shorter than 20 seconds is significant when accompanied by bradycardia below 80 beats per minute

Discharge implicationNo apnea meeting these criteria should occur during the five-to-seven-day observation period before discharge

Bradycardia with apnea

Heart-rate thresholdBelow 80 beats per minute

Applies toBradycardia accompanying an apnea shorter than 20 seconds or isolated bradycardia unrelated to feedings

Discharge implication

Documentation and Review Requirements

Documentation Required

Continued-Stay and Discharge Review

Use these criteria to support continued neonatal inpatient stay review and discharge planning. Discharge may be considered when the infant demonstrates respiratory-control maturity and meets the applicable event-free, reflux-related, or non-clinically significant spell pathway, with no additional condition requiring inpatient care.

No clinically significant apnea, bradycardia, or desaturation for five to seven days before discharge: no apnea ≥20 seconds; no apnea <20 seconds with bradycardia <80 beats per minute; no valid, prolonged, or frequent desaturation ≤85% (except transient desaturation unless supplemental oxygen is required); no isolated bradycardia <80 beats per minute unrelated to feeding; and no event requiring stimulation, artificial ventilation, or supplemental oxygen.
If clinically significant events persist near term or beyond, document evaluation for potential causes, temporal association with gastroesophageal reflux without another acute inpatient condition, and improvement with appropriate anti-reflux measures; five days of observation may not be required in this circumstance.
For non-clinically significant, self-limited apnea, document no color change, no severe bradycardia, and no need for stimulation to resume breathing, plus no clinically significant event for five to seven days.
If nasal-cannula airflow is used to address events, the infant should be free of clinically significant events for five to seven days on the same support level planned for discharge.
Confirm no additional condition requires inpatient care.

Clinical Background

Apnea of prematurity is common in premature infants and is frequently associated with bradycardia, prolonged neonatal intensive care unit stays, and parental anxiety. The condition is generally defined as cessation of breathing for at least 20 seconds, or a shorter pause accompanied by bradycardia, cyanosis, or pallor in an infant younger than 37 weeks' gestational age. Caffeine is commonly used in treatment and has a relatively long half-life in preterm infants, while feeding-associated bradycardia may have different clinical significance from events occurring during sleep.

Key Definitions

Apnea of prematurity

PopulationInfants younger than 37 weeks' gestational age

Primary definitionCessation of breathing lasting at least 20 seconds

Shorter episodeA shorter pause accompanied by bradycardia, cyanosis, or pallor

Clinically significant cardiorespiratory event

Qualifying event typesApnea, bradycardia, or oxygen desaturation

ThresholdsApnea of at least 20 seconds; bradycardia below 80 beats per minute; or valid, prolonged, or frequent desaturation at or below 85%

Intervention criterion

Policy Summary

PayerAmbetter Nevada

PolicyNICU Apnea Bradycardia Guidelines

Policy CodePolicy CP.MP.82

Change TypeModified

Effective DateOct 1, 2026

Last ReviewJun 1, 2026

Next Review DateN/A

Key ActionDocument cardiorespiratory event frequency, duration, heart rate, oxygen saturation, feeding status, interventions, and recovery requirements during the observation period.

SourceLink

On This Page

No clinically significant bradycardia should occur during the five-to-seven-day observation period before discharge

Prolonged or frequent oxygen desaturation

Oxygen-saturation threshold85% or less

Qualifying eventsValid, prolonged, or frequent oxygen desaturations associated with apnea shorter than 20 seconds

ExceptionTransient desaturation at or below 85% is excluded unless supplemental oxygen is required to resolve it

Event-free observation

Required observation periodFive to seven days before discharge

Event requirementNo clinically significant apnea, bradycardia, or desaturation during the observation period

Nasal-cannula supportWhen introduced for apnea or bradycardia, the infant must remain event-free for five to seven days on the same support level planned for discharge

Caffeine-free interval

Minimum caffeine-free intervalAt least seven days before planned discharge

Medication coveredCaffeine citrate

Discharge requirementThe infant must not have received caffeine citrate during the preceding seven days

Car-seat or car-bed assessment

Gestational-age criterionBorn at less than 37 weeks' gestation

Additional indicationRecommended for infants with other risk factors for cardiorespiratory compromise

Assessment typeCardiorespiratory stability assessment in a car seat or car bed before discharge

Documentation Required

Cardiorespiratory Event Record

Maintain a complete cardiorespiratory event record to support review of clinical significance and discharge readiness. Each apnea, bradycardia, or desaturation episode should be characterized sufficiently to determine whether it meets the policy thresholds and whether intervention was required.

Record event frequency and duration, including whether apnea lasted ≥20 seconds or was shorter than 20 seconds.
Record the lowest heart rate and whether bradycardia was <80 beats per minute, including whether an isolated bradycardia was unrelated to feeding.
Record oxygen saturation, including whether desaturation was valid, prolonged, or frequent and whether it reached ≤85%; identify transient desaturation and whether supplemental oxygen was required to resolve it.
Document feeding status or relationship to feeding, as applicable.
Document color change, including whether the event involved color change or was a non-clinically significant spell without color change.
Record interventions and response, including stimulation, supplemental oxygen, artificial ventilation/bagging, or intubation.

Documentation Required

Caffeine Discontinuation

Before planned discharge, verify and document that the infant has not received caffeine citrate for at least seven days. The last caffeine citrate dose and the resulting caffeine-free observation interval should be clearly recorded.

Document the date and time of the last caffeine citrate dose.
Document that the infant has remained caffeine-free for at least seven days before the planned discharge date.

Documentation Required

Caregiver and Home-Readiness Assessment

For discharge planning, document caregiver participation and home readiness. The plan should show that the parent(s) or caregiver(s) agree with the plan of care, have completed infant CPR training, and have an adequate home situation.

Document parent or caregiver agreement with the plan of care.
Document completion of infant cardiopulmonary resuscitation (CPR) training by the parent(s) or caregiver(s).
Document that the home situation has been assessed and deemed adequate.

Denial Risk

Failure to Meet Discharge-Readiness Criteria

Do not consider discharge readiness established when a clinically significant event occurs during the required observation period or when another policy condition remains unmet. Continued inpatient review is supported when the infant still requires acute intervention, additional respiratory support, caffeine clearance, or inpatient management of another condition.

A clinically significant cardiorespiratory event within the preceding five to seven days, including apnea ≥20 seconds, bradycardia <80 beats per minute associated with shorter apnea or isolated non-feeding bradycardia, qualifying oxygen desaturation ≤85%, or an event requiring stimulation, artificial ventilation, or supplemental oxygen, does not support routine discharge readiness.
For infants discharged with nasal-cannula airflow introduced for apnea/bradycardia, the required event-free period must occur on the same level of support planned for discharge.
Discharge readiness is not established until at least seven days have elapsed since the last caffeine citrate dose.
Discharge readiness is not established when caregiver agreement, infant CPR training, or adequate home assessment is undocumented or incomplete.
Any additional condition requiring inpatient care prevents discharge.

An event requiring stimulation, artificial ventilation such as bagging or intubation, or supplemental oxygen to restore normal breathing, heart rate, and oxygenation also qualifies